Katharina Buser

664 total citations
10 papers, 342 citations indexed

About

Katharina Buser is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Molecular Biology. According to data from OpenAlex, Katharina Buser has authored 10 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 3 papers in Genetics and 2 papers in Molecular Biology. Recurrent topics in Katharina Buser's work include AI in cancer detection (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Digital Radiography and Breast Imaging (2 papers). Katharina Buser is often cited by papers focused on AI in cancer detection (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Digital Radiography and Breast Imaging (2 papers). Katharina Buser collaborates with scholars based in Switzerland, Russia and Germany. Katharina Buser's co-authors include Johannes L. Bos, Bernd Groner, Susanne Saurer, Nancy E. Hynes, Sara C. Kozma, Christian Waldherr, Gilles Berclaz, Martin Sonnenschein, Hans J. Altermatt and Hans Hoppeler and has published in prestigious journals such as Nucleic Acids Research, European Journal of Cancer and American Journal of Roentgenology.

In The Last Decade

Katharina Buser

10 papers receiving 330 citations

Peers

Katharina Buser
Geunwon Kim United States
Hae Min Jeong South Korea
Cecilia W. Huo Australia
J Ronan United Kingdom
Leigh J. Hodson Australia
Min Sun China
Naresh Prodduturi United States
Jose J. Galvez United States
Geunwon Kim United States
Katharina Buser
Citations per year, relative to Katharina Buser Katharina Buser (= 1×) peers Geunwon Kim

Countries citing papers authored by Katharina Buser

Since Specialization
Citations

This map shows the geographic impact of Katharina Buser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katharina Buser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katharina Buser more than expected).

Fields of papers citing papers by Katharina Buser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katharina Buser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katharina Buser. The network helps show where Katharina Buser may publish in the future.

Co-authorship network of co-authors of Katharina Buser

This figure shows the co-authorship network connecting the top 25 collaborators of Katharina Buser. A scholar is included among the top collaborators of Katharina Buser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katharina Buser. Katharina Buser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Pestalozzi, Bernhard C., Christoph Tausch, Konstantin J. Dedes, et al.. (2017). Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10). BMC Cancer. 17(1). 265–265. 10 indexed citations
2.
Chappuis, Pierre O., Nicole Bürki, Katharina Buser, et al.. (2017). Genetic predisposition to breast and ovarian cancer. Schweizerische Ärztezeitung. 98(2122). 682–684. 4 indexed citations
3.
Gautschi, Oliver, Katharina König, Reinhard Büttner, et al.. (2015). Mutation Profiling of Lung Cancers with Long-Term Response to Gefitinib Therapy. Oncology Research and Treatment. 38(11). 560–569. 5 indexed citations
4.
Tausch, C., Silke Zimmermann, Roger von Moos, et al.. (2015). 1943 Adjuvant treatment recommendations for ER+ early breast cancer patients by Swiss tumor boards (SAKK 26/10). European Journal of Cancer. 51. S313–S313. 1 indexed citations
5.
Waldherr, Christian, Gilles Berclaz, Hans Jörg Altermatt, et al.. (2015). Tomosynthesis-guided vacuum-assisted breast biopsy: A feasibility study. European Radiology. 26(6). 1582–1589. 37 indexed citations
6.
Waldherr, Christian, et al.. (2012). Value of One-View Breast Tomosynthesis Versus Two-View Mammography in Diagnostic Workup of Women With Clinical Signs and Symptoms and in Women Recalled From Screening. American Journal of Roentgenology. 200(1). 226–231. 70 indexed citations
7.
Eisenhauer, Elizabeth A., W.W. ten Bokkel Huinink, Kenneth D. Swenerton, et al.. (1998). European-Canadian randomized trial of Paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion. 3(1). 171–184. 44 indexed citations
8.
Goldhirsch, Aron, et al.. (1988). Ovarian Cancer and Tumor Markers: Sialic Acid, Galactosyltransferase and CA-125. Oncology. 45(4). 281–286. 13 indexed citations
9.
Kozma, Sara C., Katharina Buser, Susanne Saurer, et al.. (1987). The human c-Kirstenrasgene is activated by a novel mutation in codon 13 in the breast carcinoma cell line MDA-MB231. Nucleic Acids Research. 15(15). 5963–5971. 110 indexed citations
10.
Buser, Katharina, et al.. (1982). Effect of cold environment on skeletal muscle mitochondria in growing rats. Cell and Tissue Research. 225(2). 427–36. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026